← All companies

NBP

NovaBridge Biosciences

NBP Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.61

-0.03 -1.83%

Key statistics

from XBRL data in SEC filings

Market cap

$427M

Revenue (TTM)

$632K

Net income (TTM)

-$46.3M

EPS (TTM)

$-0.21

P/E ratio

—

Dividend yield

—

Free cash flow

-$20.6M

Cash

$211M

Total assets

$261M

Gross margin

—

52-week range

$1.46 – $6.79

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 24, 2026 6-K Jul 17, 2026 6-K Jun 29, 2026 20-F/A Jun 16, 2026 6-K Jun 16, 2026 6-K Jun 16, 2026 6-K Apr 22, 2026 6-K Apr 7, 2026 20-F Apr 7, 2026 6-K Mar 16, 2026 6-K Mar 9, 2026 6-K Mar 3, 2026 6-K Feb 25, 2026 6-K Feb 19, 2026 6-K Feb 17, 2026 6-K/A Feb 6, 2026 6-K Feb 6, 2026 6-K Jan 22, 2026 6-K Jan 22, 2026 6-K Jan 16, 2026 6-K Jan 6, 2026 6-K Dec 18, 2025 6-K Dec 10, 2025 6-K Dec 4, 2025 6-K FORM 6-K Oct 31, 2025 6-K Oct 30, 2025 6-K Oct 29, 2025 6-K Oct 28, 2025 6-K Oct 24, 2025 6-K Oct 24, 2025 6-K/A Oct 24, 2025 6-K Oct 23, 2025 6-K Oct 22, 2025 6-K Oct 16, 2025 6-K Oct 6, 2025 6-K Sep 24, 2025 6-K Sep 8, 2025 6-K Aug 25, 2025 6-K Aug 20, 2025 6-K Aug 11, 2025